Modelling the cost-effectiveness of person-centred care for patients with acute coronary syndrome

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Modelling the cost-effectiveness of person-centred care for patients with acute coronary syndrome. / Pirhonen, Laura; Gyllensten, Hanna; Fors, Andreas; Bolin, Kristian.

In: European Journal of Health Economics, Vol. 21, No. 9, 2020, p. 1317-1327.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Pirhonen, L, Gyllensten, H, Fors, A & Bolin, K 2020, 'Modelling the cost-effectiveness of person-centred care for patients with acute coronary syndrome', European Journal of Health Economics, vol. 21, no. 9, pp. 1317-1327. https://doi.org/10.1007/s10198-020-01230-8

APA

Pirhonen, L., Gyllensten, H., Fors, A., & Bolin, K. (2020). Modelling the cost-effectiveness of person-centred care for patients with acute coronary syndrome. European Journal of Health Economics, 21(9), 1317-1327. https://doi.org/10.1007/s10198-020-01230-8

Vancouver

Pirhonen L, Gyllensten H, Fors A, Bolin K. Modelling the cost-effectiveness of person-centred care for patients with acute coronary syndrome. European Journal of Health Economics. 2020;21(9):1317-1327. https://doi.org/10.1007/s10198-020-01230-8

Author

Pirhonen, Laura ; Gyllensten, Hanna ; Fors, Andreas ; Bolin, Kristian. / Modelling the cost-effectiveness of person-centred care for patients with acute coronary syndrome. In: European Journal of Health Economics. 2020 ; Vol. 21, No. 9. pp. 1317-1327.

Bibtex

@article{fa47f5ce267b45a484114337f710b5ac,
title = "Modelling the cost-effectiveness of person-centred care for patients with acute coronary syndrome",
abstract = "Background: Person-centred care has been shown to be cost-effective compared to usual care for several diseases, including acute coronary syndrome, in a short-term time perspective (< 2 years). The cost-effectiveness of person-centred care in a longer time perspective is largely unknown. Objectives: To estimate the mid-term cost-effectiveness of person-centred care compared to usual care for patients (< 65) with acute coronary syndrome, using a 2-year and a 5-year time perspective. Methods: The mid-term cost-effectiveness of person-centred care compared to usual care was estimated by projecting the outcomes observed in a randomized-controlled trial together with data from health registers and data from the scientific literature, 3 years beyond the 2-year follow-up, using the developed simulation model. Probabilistic sensitivity analyses were performed using Monte Carlo simulation. Results: Person-centred care entails lower costs and improved effectiveness as compared to usual care, for a 2-year time and a 5-year perspective. Monte Carlo simulations suggest that the likelihoods of the person-centred care being cost-effective compared to usual care were between 80 and 99% and between 75 and 90% for a 2-year and a 5-year time perspective (using a 500,000 SEK/QALY willingness-to-pay threshold). Conclusions: Person-centred care was less costly and more effective compared to usual care in a 2-year and a 5-year time perspective for patients with acute coronary syndrome under the age of 65.",
keywords = "Acute coronary syndrome, Markov model, Mid-term cost-effectiveness, Person-centred care, Randomized-controlled trial",
author = "Laura Pirhonen and Hanna Gyllensten and Andreas Fors and Kristian Bolin",
note = "Publisher Copyright: {\textcopyright} 2020, The Author(s).",
year = "2020",
doi = "10.1007/s10198-020-01230-8",
language = "English",
volume = "21",
pages = "1317--1327",
journal = "European Journal of Health Economics",
issn = "1618-7598",
publisher = "Springer",
number = "9",

}

RIS

TY - JOUR

T1 - Modelling the cost-effectiveness of person-centred care for patients with acute coronary syndrome

AU - Pirhonen, Laura

AU - Gyllensten, Hanna

AU - Fors, Andreas

AU - Bolin, Kristian

N1 - Publisher Copyright: © 2020, The Author(s).

PY - 2020

Y1 - 2020

N2 - Background: Person-centred care has been shown to be cost-effective compared to usual care for several diseases, including acute coronary syndrome, in a short-term time perspective (< 2 years). The cost-effectiveness of person-centred care in a longer time perspective is largely unknown. Objectives: To estimate the mid-term cost-effectiveness of person-centred care compared to usual care for patients (< 65) with acute coronary syndrome, using a 2-year and a 5-year time perspective. Methods: The mid-term cost-effectiveness of person-centred care compared to usual care was estimated by projecting the outcomes observed in a randomized-controlled trial together with data from health registers and data from the scientific literature, 3 years beyond the 2-year follow-up, using the developed simulation model. Probabilistic sensitivity analyses were performed using Monte Carlo simulation. Results: Person-centred care entails lower costs and improved effectiveness as compared to usual care, for a 2-year time and a 5-year perspective. Monte Carlo simulations suggest that the likelihoods of the person-centred care being cost-effective compared to usual care were between 80 and 99% and between 75 and 90% for a 2-year and a 5-year time perspective (using a 500,000 SEK/QALY willingness-to-pay threshold). Conclusions: Person-centred care was less costly and more effective compared to usual care in a 2-year and a 5-year time perspective for patients with acute coronary syndrome under the age of 65.

AB - Background: Person-centred care has been shown to be cost-effective compared to usual care for several diseases, including acute coronary syndrome, in a short-term time perspective (< 2 years). The cost-effectiveness of person-centred care in a longer time perspective is largely unknown. Objectives: To estimate the mid-term cost-effectiveness of person-centred care compared to usual care for patients (< 65) with acute coronary syndrome, using a 2-year and a 5-year time perspective. Methods: The mid-term cost-effectiveness of person-centred care compared to usual care was estimated by projecting the outcomes observed in a randomized-controlled trial together with data from health registers and data from the scientific literature, 3 years beyond the 2-year follow-up, using the developed simulation model. Probabilistic sensitivity analyses were performed using Monte Carlo simulation. Results: Person-centred care entails lower costs and improved effectiveness as compared to usual care, for a 2-year time and a 5-year perspective. Monte Carlo simulations suggest that the likelihoods of the person-centred care being cost-effective compared to usual care were between 80 and 99% and between 75 and 90% for a 2-year and a 5-year time perspective (using a 500,000 SEK/QALY willingness-to-pay threshold). Conclusions: Person-centred care was less costly and more effective compared to usual care in a 2-year and a 5-year time perspective for patients with acute coronary syndrome under the age of 65.

KW - Acute coronary syndrome

KW - Markov model

KW - Mid-term cost-effectiveness

KW - Person-centred care

KW - Randomized-controlled trial

U2 - 10.1007/s10198-020-01230-8

DO - 10.1007/s10198-020-01230-8

M3 - Journal article

C2 - 32895879

AN - SCOPUS:85090307900

VL - 21

SP - 1317

EP - 1327

JO - European Journal of Health Economics

JF - European Journal of Health Economics

SN - 1618-7598

IS - 9

ER -

ID: 391830398